A$5.9 -0.0 -0.5%
Last Trade - 7:10am
| Market Cap | £228.8m |
| Enterprise Value | £212.0m |
| Revenue | £13.5m |
| Position in Universe | 460th / 1899 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 30th Jun | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 11.6 | 15.5 | 18.4 | 17.5 | 21.3 | 22.9 | 26.0 | 26.1 | +14.5% | ||
| +74.5 | +1.9 | +14.9 | -86.7 | +288.8 | -64.0 | |||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Medical Developments International Limited is an Australia-based healthcare company. The Company is engaged in the manufacture and distribution of a pharmaceutical drug, and medical and veterinary equipment. The Company operates through three segments: Pharmaceuticals, Medical Devices and Veterinary products. The Pharmaceuticals segment is engaged in the sale of Penthrox primarily within Australia and the United Kingdom, and some sales in New Zealand, Eastern Europe, the Middle East and South America. The Medical Devices segment is engaged in the sale of medical devices, particularly the Space Chamber and Breath-Alert PeakFlow meters, primarily within Australia and New Zealand, and some sales in Asia, Europe, the Middle East and North America. The Veterinary Products segment is engaged in the sale of veterinary products within Australia, Europe and the United States. The Company offers a range of products in the areas of pain management, and asthma and resuscitation.
| Last Annual | June 30th, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | September 16, 2003 |
| Public Since | December 15, 2003 |
| No. of Shareholders: | n/a |
| No. of Employees: | 65 |
| Sector | Healthcare |
| Industry | Pharmaceuticals |
| Index | S&P/ASX All Ordinaries , S&P/ASX 300 , ASX Small Ordinaries , |
| Exchange | Australian Stock Exchange - SEATS |
| Shares in Issue | 69,454,260 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | 4 Caribbean Dr, MELBOURNE, 3179, Australia |
| Web | http://www.medicaldev.com/ |
| Phone | +61 3 95471888 |
| Contact | () |
| Auditors | Deloitte Touche Tohmatsu |
As of 7:10am, shares in Medical Developments International are trading at A$5.9, giving the company a market capitalisation of £228.8m. This share price information is delayed by 15 minutes.
Shares in Medical Developments International are currently trading at A$5.9 and the price has moved by -24.46% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Medical Developments International price has moved by -42.49% over the past year.
Of the analysts with advisory recommendations for Medical Developments International, there are there are currently 2 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Medical Developments International is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Medical Developments International is scheduled to issue upcoming financial results on the following dates:
Medical Developments International does not currently pay a dividend.
Medical Developments International does not currently pay a dividend.
Medical Developments International does not currently pay a dividend.
To buy shares in Medical Developments International you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Medical Developments International are currently trading at A$5.9, giving the company a market capitalisation of £228.8m.
Here are the trading details for Medical Developments International:
Based on an overall assessment of its quality, value and momentum, Medical Developments International is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Medical Developments International are currently priced at A$5.9. At that level they are trading at 19.22% discount to the analyst consensus target price of 0.00.
Analysts covering Medical Developments International currently have a consensus Earnings Per Share (EPS) forecast of -0.054 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medical Developments International. Over the past six months, the relative strength of its shares against the market has been -10.34%. At the current price of A$5.9, shares in Medical Developments International are trading at -1.8% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Medical Developments International.
Medical Developments International's management team is headed by:
Here are the top five shareholders of Medical Developments International based on the size of their shareholding:
